With increasing patient demand for more effective and faster-acting weight loss solutions, Tirzepatide's potential for broader indications and ongoing positive clinical outcomes are expected to drive segmental growth in the coming years
Its manufacturer is careful to distinguish their device from microneedling, framing it as a delivery system rather than a wounding system
Phase II Open-Label Study of Sunitinib in Patients with Advanced Breast Cancer
Understanding how different ingredients work allows for more thoughtful and sustainable skincare routines
the Danish cohort used other antidiabetic agents as the reference, while the Israeli study compared GLP-1RA users against non-users within the IBD-diabetes population, making cross-study comparison difficult
Similar results were obtained for NHX (Figure 4), a metal chelator that we previously identified as a candidate inhibitor for CBS (Xu et al., 2019